Marjolein de Bruijn

Dr. Marjolein de Bruijn

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
EPEsmee K. van der Ploeg
Esmee K. van der Ploeg
KGKorneliusz Golebski
Korneliusz Golebski
MNMenno van Nimwegen
Menno van Nimwegen
JFJoannah R. Fergusson
Joannah R. Fergusson
BHBalthasar A. Heesters
Balthasar A. Heesters
SBSuzanne M. Bal
Suzanne M. Bal
An inflammatory CD45RO + ILC2 population found in inflamed human nasal tissue is steroid resistant and linked to type 2 immunopathology.

26 May 2023 in Science Immunology
Verified
Journal Article
Closed access
MGMandy van Gulijk
Mandy van Gulijk
AKAnneloes van Krimpen
Anneloes van Krimpen
SSSjoerd T.T. Schetters
Sjoerd T.T. Schetters
MEMike Eterman
Mike Eterman
MEMarit J. van Elsas
Marit J. van Elsas
THThorbald van Hall
Thorbald van Hall
Despite the clinical success of immune checkpoint blockade (ICB), in certain cancer types, most patients with cancer do not respond well. Furthermore, in patients for whom ICB is initially successful, this is often short-lived because of the development of resistance to ICB. The mechanisms underlying primary or secondary ICB resistance are incompletely understood. Here, we identified preferential activation and enhanced suppressive capacity of regulatory T cells (T reg cells) in αPD-L1 therapy–resistant solid tumor–bearing mice. T reg cell depletion reversed resistance to αPD-L1 with concomitant expansion of effector T cells. Moreover, we found that tumor-infiltrating T reg cells in human patients with skin cancer, and in patients with non–small cell lung cancer, up-regulated a suppressive transcriptional gene program after ICB treatment, which correlated with lack of treatment response. αPD-1/PD-L1–induced PD-1 + T reg cell activation was also seen in peripheral blood of patients with lung cancer and mesothelioma, especially in nonresponders. Together, these data reveal that treatment with αPD-1 and αPD-L1 unleashes the immunosuppressive role of T reg cells, resulting in therapy resistance, suggesting that T reg cell targeting is an important adjunct strategy to enhance therapeutic efficacy.

28 July 2023 in Science Immunology
Verified
Journal Article
Closed access
ASAnne Onrust-Van Schoonhoven
Anne Onrust-Van Schoonhoven
MBMarjolein de Bruijn
Marjolein de Bruijn
BSBernard Stikker
Bernard Stikker
RBRutger Brouwer
Rutger Brouwer
GBGert-Jan Braunstahl
Gert-Jan Braunstahl
RSRalph Stadhouders
Ralph Stadhouders
Memory T cells provide long-lasting defense responses through their ability to rapidly reactivate, but how they efficiently “recall” an inflammatory transcriptional program remains unclear. Here, we show that human CD4 + memory T helper 2 (T H 2) cells carry a chromatin landscape synergistically reprogrammed at both one-dimensional (1D) and 3D levels to accommodate recall responses, which is absent in naive T cells. In memory T H 2 cells, recall genes were epigenetically primed through the maintenance of transcription-permissive chromatin at distal (super)enhancers organized in long-range 3D chromatin hubs. Precise transcriptional control of key recall genes occurred inside dedicated topologically associating domains (“memory TADs”), in which activation-associated promoter-enhancer interactions were preformed and exploited by AP-1 transcription factors to promote rapid transcriptional induction. Resting memory T H 2 cells from patients with asthma showed premature activation of primed recall circuits, linking aberrant transcriptional control of recall responses to chronic inflammation. Together, our results implicate stable multiscale reprogramming of chromatin organization as a key mechanism underlying immunological memory and dysfunction in T cells.

1 July 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ITIrma Tindemans
Irma Tindemans
ASAnne van Schoonhoven
Anne van Schoonhoven
AKAlex KleinJan
Alex KleinJan
MBMarjolein de Bruijn
Marjolein de Bruijn
MLMelanie Lukkes
Melanie Lukkes
Rudi HendriksRudi Hendriks
Rudi Hendriks
Allergic asthma is mediated by Th2 responses to inhaled allergens. Although previous experiments indicated that Notch signaling activates expression of the key Th2 transcription factor Gata3, it remains controversial how Notch promotes allergic airway inflammation. Here we show that T cell–specific Notch deficiency in mice prevented house dust mite–driven eosinophilic airway inflammation and significantly reduced Th2 cytokine production, serum IgE levels, and airway hyperreactivity. However, transgenic Gata3 overexpression in Notch-deficient T cells only partially rescued this phenotype. We found that Notch signaling was not required for T cell proliferation or Th2 polarization. Instead, Notch-deficient in vitro–polarized Th2 cells showed reduced accumulation in the lungs upon in vivo transfer and allergen challenge, as Notch-deficient Th2 cells were retained in the lung-draining lymph nodes. Transcriptome analyses and sequential adoptive transfer experiments revealed that while Notch-deficient lymph node Th2 cells established competence for lung migration, they failed to upregulate sphingosine-1-phosphate receptor 1 (S1PR1) and its critical upstream transcriptional activator Krüppel-like factor 2 (KLF2). As this KLF2/S1PR1 axis represents the essential cell-intrinsic regulator of T cell lymph node egress, we conclude that the druggable Notch signaling pathway licenses the Th2 response in allergic airway inflammation via promoting lymph node egress.

29 July 2021 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JRJasper Rip
Jasper Rip
MBMarjolein de Bruijn
Marjolein de Bruijn
SNStefan F.H. Neys
Stefan F.H. Neys
SSSimar Pal Singh
Simar Pal Singh
JWJonas Willar
Jonas Willar
Odilia CornethOdilia Corneth
Odilia Corneth
Bruton′s tyrosine kinase (Btk) is a crucial signaling molecule in BCR signaling and a key regulator of B‐ cell differentiation and function. Btk inhibition has shown impressive clinical efficacy in various B‐cell malignancies. However, it remains unknown whether inhibition additionally induces changes in BCR signaling due to feedback mechanisms, a phenomenon referred to as BCR rewiring. In this report, we studied the impact of Btk activity on major components of the BCR signaling pathway in mice. As expected, NF‐κB and Akt/S6 signaling was decreased in Btk‐deficient B cells. Unexpectedly, phosphorylation of several proximal signaling molecules, including CD79a, Syk, and PI3K, as well as the key Btk‐effector PLCγ2 and the more downstream kinase Erk, were significantly increased. This pattern of BCR rewiring was essentially opposite in B cells from transgenic mice overexpressing Btk. Importantly, prolonged Btk inhibitor treatment of WT mice or mice engrafted with leukemic B cells also resulted in increased phosho‐CD79a and phospho‐PLCγ2 in B cells. Our findings show that Btk enzymatic function determines phosphorylation of proximal and distal BCR signaling molecules in B cells. We conclude that Btk inhibitor treatment results in rewiring of BCR signaling, which may affect both malignant and healthy B cells.

11 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
RVRoos Verstegen
Roos Verstegen
MZMarit Zuurveld
Marit Zuurveld
STSuzan Thijssen
Suzan Thijssen
MBMarjolein de Bruijn
Marjolein de Bruijn
IAIngrid van Ark
Ingrid van Ark
LWLinette E.M. Willemsen
Linette E.M. Willemsen
Background/Objectives: The gut microbiome has an important role in immune regulation, and dietary interventions that support a balanced microbiota may help to prevent the development of allergic asthma. Dietary fibers can beneficially affect the intestinal microbiome, but due to the diversity of fiber types, the effects differ. In this study, we investigate the preventive effects of two mixes of short-chain and long-chain (1:1 and 9:1 ratio) fructo-oligosaccharides (FOS) in a mouse model of house dust mite (HDM)-induced allergic asthma. Methods: BALB/c mice received FOS-supplemented (1% w/w) diets before and during intranasal exposures to HDM. Endpoint airway hyperreactivity measurements were performed, followed by the collection of bronchoalveolar lavage fluid (BALF), lung, serum and cecum content. Fecal microbiome composition was determined by DNA sequencing and short-chain fatty acid (SCFA) levels were determined in the cecum, serum and lung. Results: Fecal microbiome analyses revealed an increased abundance of Prevotellaceae after FOS1:1 supplementation in HDM-allergic mice. Additionally, FOS1:1 protected against an HDM-induced increase in basal airway resistance. Both FOS1:1 and FOS9:1 restored the systemic acetate levels in HDM-allergic mice. The two FOS supplementations did not affect HDM-induced inflammatory cell influx in the BALF. However, FOS1:1 increased the frequency of Th1-cells and prevented an HDM-induced increase in the Th2/Th1 balance. Upon ex vivo restimulation with HDM, lung cell suspensions of FOS1:1-fed mice produced less type 2-related cytokines compared to control-supplemented mice, and FOS9:1 followed a similar pattern. Conclusions: Specific short-chain and long-chain FOS ratios differentially affect the microbiome and immune system in a mouse model with HDM-induced allergic airway inflammation. Dietary supplementation with FOS1:1 shifts the immune response away from type 2, suggesting that dietary fibers like FOS1:1 may contribute as a part of a broader strategy to modulate HDM-induced allergic asthma.